The Physician Executive has his thoughts, but I think the reason is much simpler. Repackaging two cheap, generic medications into an expensive, brand-name pill is generally not a good business model for success.
Why did BiDil fail?
ADVERTISEMENT
More in Uncategorized
Past Week
-
The loss of community pharmacy expertise
-
Accountable care cooperatives: a community-owned health care fix
-
Why fee-for-service reform is needed
-
Preventing physician burnout before it begins in med school [PODCAST]
-
What is shared truth and why does it matter?
-
Reflecting on the significance of World AIDS Day from the 1980s to now
-
Past 6 Months
Recent Posts
-
Preventing physician burnout before it begins in med school [PODCAST]
-
Why we can’t forget public health
-
Why pediatric leadership fails without logistics and tactics
-
Why invisible labor in medicine prevents burnout
-
The risk of ideology in gender medicine
-
The economic case for investing in tobacco cessation
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
